|Age-related macular degeneration|
RD Jager, WF Mieler, JW Miller
New England Journal of Medicine 358 (24), 2606-2617, 2008
|Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials-TAP report 1|
Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP ...
Arch ophthalmol 117, 1329-1345, 1999
|Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy|
AP Adamis, JW Miller, MT Bernal, DJ D'Amico, J Folkman, TK Yeo, ...
American journal of ophthalmology 118 (4), 445-450, 1994
|Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult …|
American journal of ophthalmology 131 (5), 541-560, 2001
|Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model|
JW Miller, AP Adamis, DT Shima, PA D'Amore, RS Moulton, MS O'Reilly, ...
The American journal of pathology 145 (3), 574, 1994
|Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.|
Archives of ophthalmology (Chicago, Ill.: 1960) 119 (2), 198-207, 2001
|Inhibition of vascular endothelial growth factor prevents retinal ischemia—associated iris neovascularization in a nonhuman primate|
AP Adamis, DT Shima, MJ Tolentino, ES Gragoudas, N Ferrara, ...
Archives of ophthalmology 114 (1), 66-71, 1996
|Prevention of experimental choroidal neovascularization with intravitreal anti–vascular endothelial growth factor antibody fragment|
MG Krzystolik, MA Afshari, AP Adamis, J Gaudreault, ES Gragoudas, ...
Archives of ophthalmology 120 (3), 338-346, 2002
|Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate|
MJ Tolentino, JW Miller, ES Gragoudas, FA Jakobiec, E Flynn, ...
Ophthalmology 103 (11), 1820-1828, 1996
|Principles and practice of ophthalmology|
DM Albert, FA Jakobiec
WB Saunders company, 2000
|VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal Neovascularization|
S Ishida, T Usui, K Yamashiro, Y Kaji, S Amano, Y Ogura, T Hida, ...
The Journal of experimental medicine 198 (3), 483-489, 2003
|Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration|
W Chen, D Stambolian, AO Edwards, KE Branham, M Othman, ...
Proceedings of the National Academy of Sciences 107 (16), 7401-7406, 2010
|Diffusion of high molecular weight compounds through sclera|
J Ambati, CS Canakis, JW Miller, ES Gragoudas, A Edwards, ...
Investigative ophthalmology & visual science 41 (5), 1181-1185, 2000
|Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study|
JW Miller, U Schmidt-Erfurth, M Sickenberg, CJ Pournaras, H Laqua, ...
Archives of ophthalmology 117 (9), 1161-1173, 1999
|Tumor necrosis factor-α mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma|
T Nakazawa, C Nakazawa, A Matsubara, K Noda, T Hisatomi, H She, ...
Journal of Neuroscience 26 (49), 12633-12641, 2006
|Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study|
U Schmidt-Erfurth, JW Miller, M Sickenberg, H Laqua, I Barbazetto, ...
Archives of Ophthalmology 117 (9), 1177-1187, 1999
|Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate|
MJ Tolentino, JW Miller, ES Gragoudas, K Chatzistefanou, N Ferrara, ...
Archives of Ophthalmology 114 (8), 964-970, 1996
|Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.|
KJ Blinder, MS Blumenkranz, NM Bressler, SB Bressler, G Donato, ...
Ophthalmology 110 (4), 667-673, 2003
|Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy|
JW Miller, AP Adamis, LP Aiello
Diabetes/metabolism reviews 13 (1), 37-50, 1997
|Vascular endothelial growth factor a in intraocular vascular disease|
JW Miller, J Le Couter, EC Strauss, N Ferrara
Ophthalmology 120 (1), 106-114, 2013